References
George JN (2015) Measuring ADAMTS13 activity in patients with suspected thrombotic thrombocytopenic purpura: when, how, and why? Transfusion 55:11–13
Ferrari S, Scheiflinger F, Rieger M et al (2007) Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Blood 109:2815–2822
Kornacker M, Luft T, Ho AD et al (2005) Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases. Eur J Haematol 74:250–253
Gallerani E, Lerch E, Romagnani E et al (2006) Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab. Eur J Haematol 77:527–529
Munoz J, Hughes A (2012) Thrombotic thrombocytopenic purpura after autologous peripheral stem cell transplantation. Blood 119:5620
Nakamura Y, Mitani N, Ishii A et al (2013) Idiopathic pneumonia syndrome with thrombotic microangiopathy-related changes after allogeneic hematopoietic stem cell transplantation. Int J Hematol 98:496–498
Peffault de Latour R, Xhaard A, Fremeaux-Bacchi V et al (2013) Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy. Br J Haematol 161:279–280
Morita R, Hashino S, Shirai S et al (2008) Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma. Int J Hematol 88:248–250
Moore H, Romeril K (2011) Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib. Intern Med J 41:348–350
Mehta N, Saxena A, Niesvizky R (2012) Bortezomib-induced thrombotic thrombocytopaenic purpura. BMJ Case Rep: 2012
Salmenniemi U, Remes K (2012) Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma. Hematol Rep 4:e13
Chan KL, Filshie R, Nandurkar H et al. (2015) Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma. Leuk Lymphoma:1–2
Hobeika L, Self SE, Velez JC (2014) Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma. BMC Nephrol 15:156
Sullivan MR, Danilov AV, Lansigan F et al. (2014) Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange. J Clin Apher
Xu B, Ritchie D (2010) Thrombotic thrombocytopenic purpura associated with disseminated varicella zoster in a multiple myeloma patient. Intern Med J 40:e7–e8
Xiao X, Zhong HY, Zhang GS et al (2013) Thrombotic thrombocytopenic purpura as initial and major presentation of multiple myeloma. J Thromb Thrombolysis 36:422–423
Lechner K, Obermeier HL (2012) Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases. Medicine (Baltimore) 91:195–205
Hofmeister CC, Jin M, Cataland SR et al (2010) TTP disease course is independent of myeloma treatment and response. Am J Hematol 85:304–306
Acknowledgments
This work was not supported by any grants.
Conflict of interest
The authors declare no conflicts of interest.
Informed consent
The patient in question gave written informed consent for her participation in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheah, C.Y., Orlowski, R.Z., Manasanch, E.E. et al. Thrombotic thrombocytopenic purpura in a patient with lenalidomide-responsive multiple myeloma. Ann Hematol 94, 1605–1607 (2015). https://doi.org/10.1007/s00277-015-2421-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-015-2421-0